Irobi Joy, Dierick Ines, Jordanova Albena, Claeys Kristl G, De Jonghe Peter, Timmerman Vincent
Peripheral Neuropathy Group, Department of Molecular Genetics, Flanders Interuniversity Institute for Biotechnology, University of Antwerp, Antwerpen, Belgium.
Neuromolecular Med. 2006;8(1-2):131-46. doi: 10.1385/nmm:8:1-2:131.
The hereditary motor neuronopathies (HMN [MIM 158590]) are a heterogeneous group of disorders characterized by an exclusive involvement of the motor part of the peripheral nervous system. They are usually subdivided in proximal HMN, i.e., the classical spinal muscular atrophy syndromes and distal hereditary motor neuronopathies (distal HMN) that clinically resemble Charcot-Marie-Tooth syndromes. In this review, we concentrate on distal HMN. The distal HMN are clinically and genetically heterogeneous and were initially subdivided in seven subtypes according to mode of inheritance, age at onset, and clinical evolution. Recent studies have shown that these subtypes are still heterogeneous at the molecular genetic level and novel clinical and genetic entities have been delineated. Since the introduction of positional cloning, 13 chromosomal loci and seven disease-associated genes have been identified for autosomal-dominant, autosomal-recessive, and X-linked recessive distal HMN. Most of the genes involved encode protein with housekeeping functions, such as RNA processing, translation synthesis, stress response, apoptosis, and others code for proteins involved in retrograde survival. Motor neurons of the anterior horn of the spinal cord seems to be vulnerable to defects in these housekeeping proteins, likely because their large axons have higher metabolic requirements for maintenance, transport over long distances and precise connectivity. Understanding the molecular pathomechanisms for mutations in these genes that are ubiquitous expressed will help unravel the neuronal mechanisms that underlie motor neuropathies leading to denervation of distal limb muscles, and might generate new insights for future therapeutic strategies.
遗传性运动神经元病(HMN [MIM 158590])是一组异质性疾病,其特征是仅累及周围神经系统的运动部分。它们通常分为近端HMN,即经典的脊髓性肌萎缩综合征和远端遗传性运动神经元病(远端HMN),后者在临床上类似于夏科-马里-图斯综合征。在本综述中,我们专注于远端HMN。远端HMN在临床和遗传上具有异质性,最初根据遗传方式、发病年龄和临床演变分为七个亚型。最近的研究表明,这些亚型在分子遗传水平上仍然存在异质性,并且已经确定了新的临床和遗传实体。自从引入定位克隆技术以来,已经为常染色体显性、常染色体隐性和X连锁隐性远端HMN鉴定出13个染色体位点和7个疾病相关基因。大多数相关基因编码具有看家功能的蛋白质,如RNA加工、翻译合成、应激反应、细胞凋亡等,其他基因则编码参与逆行存活的蛋白质。脊髓前角的运动神经元似乎易受这些看家蛋白质缺陷的影响,可能是因为它们的大轴突对维持、长距离运输和精确连接具有更高的代谢需求。了解这些普遍表达的基因发生突变的分子致病机制,将有助于揭示导致远端肢体肌肉失神经支配的运动神经病的神经元机制,并可能为未来的治疗策略提供新的见解。